1.38
Organigram Global Inc stock is traded at $1.38, with a volume of 443.75K.
It is up +2.99% in the last 24 hours and down -2.82% over the past month.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
See More
Previous Close:
$1.34
Open:
$1.35
24h Volume:
443.75K
Relative Volume:
0.47
Market Cap:
$188.15M
Revenue:
$200.55M
Net Income/Loss:
$11.80M
P/E Ratio:
15.88
EPS:
0.0869
Net Cash Flow:
$-26.13M
1W Performance:
-0.72%
1M Performance:
-2.82%
6M Performance:
-21.14%
1Y Performance:
+28.97%
Organigram Global Inc Stock (OGI) Company Profile
Compare OGI vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OGI
Organigram Global Inc
|
1.38 | 182.69M | 200.55M | 11.80M | -26.13M | 0.0869 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.29 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
116.71 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.74 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.46 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
541.60 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Jul-17-24 | Resumed | Canaccord Genuity | Speculative Buy |
| Apr-15-24 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Jan-13-23 | Upgrade | Stifel | Hold → Buy |
| Jan-12-22 | Upgrade | Canaccord Genuity | Hold → Speculative Buy |
| May-11-21 | Upgrade | CIBC | Sector Underperform → Neutral |
| Apr-14-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-08-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Mar-10-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-13-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jan-13-21 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jul-07-20 | Initiated | Alliance Global Partners | Buy |
| Jan-15-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-13-20 | Initiated | BofA/Merrill | Underperform |
| Jan-09-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-12-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-19 | Upgrade | Jefferies | Hold → Buy |
View All
Organigram Global Inc Stock (OGI) Latest News
Organigram Says Proxy Firm for Sanity Group Purchase - Tobacco Reporter
ISS recommends Organigram shareholders approve Sanity acquisition By Investing.com - Investing.com Canada
ISS backs Organigram (NASDAQ: OGI) €113.4M Sanity Group deal - Stock Titan
Organigram (OGI) Gains Support for Sanity Group Acquisition - GuruFocus
ISS Backs Organigram’s Premium-Priced Acquisition of Sanity Group - TipRanks
ISS recommends Organigram shareholders approve Sanity acquisition - Investing.com
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH - The Globe and Mail
Organigram Global Inc. (OGI) Expands Into U.S. THC Beverage Market Across 25 States - MSN
Update Report: Is Organigram Global Inc attractive for institutional investors2026 Rallies & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Organigram bets big on Europe with Sanity Group takeover - MSN
OGI SEC FilingsOrganigram Global Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Organigram Global Inc. (OGI) sees C$4 target on improved outlook - MSN
Organigram achieves record financial results and expands market leadership - MSN
Organigram Extends SHRED Brand Into Fast-Acting Shot-Sized Cannabis Beverages - TipRanks
Organigram Sets March 30 Vote on Sanity Group Acquisition and BAT-Funded Expansion - The Globe and Mail
Promising Cannabis Stocks To Follow NowMarch 11th - MarketBeat
Sanity Group deal and BAT C$65.2M financing reshape Organigram (TSX: OGI) - Stock Titan
Canada’s Organigram makes $268M move into German cannabis market - Telegraph-Journal
Fast-Acting Cannabis Shots - Trend Hunter
Special Meeting For Organigram (NASDAQ:OGI) - Seeking Alpha
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting - Barchart.com
Organigram Global (NASDAQ:OGI) Stock Price Down 2%Should You Sell? - MarketBeat
Organigram Global Sets March 30 Vote on Transformative Acquisition of Germany’s Sanity Group - TipRanks
Analyst Downgrade: How does Organigram Global Inc correlate with Nasdaq2026 Levels & Daily Chart Pattern Signals - baoquankhu1.vn
Promising Cannabis Stocks To Follow TodayMarch 7th - MarketBeat
Dip Buying: Will Organigram Global Inc outperform its industry peersMarket Performance Summary & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Organigram Global Expands FAST Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - marketscreener.com
Best Cannabis Stocks To Add to Your WatchlistMarch 5th - MarketBeat
Breakouts Watch: Is Organigram Global Incs ROIC above industry averageJuly 2025 Closing Moves & Safe Capital Growth Plans - baoquankhu1.vn
SHRED Shotz cannabis beverage launched by Organigram Global (OGI) - Stock Titan
Organigram Global Expands FAST Platform with Launch of SHRED Shotz Cannabis Product - geneonline.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity - The AI Journal
Organigram Global Moves to Acquire Germany’s Sanity Group in Financed Deal with BAT Support - The Globe and Mail
Organigram Global Inc. (OGI) Sees C$4 Target on Improved Outlook - Finviz
Organigram (NASDAQ: OGI) to buy Sanity Group and deepen European reach - Stock Titan
OGI PE Ratio & Valuation, Is OGI Overvalued - Intellectia AI
Organigram Global Inc. (OGI) reports Q1 revenue of $97.3 million, with a consensus of $73.15 million - MSN
Document - SEC.gov
What is Organigram Global Inc.’s valuation compared to sectorWeekly Profit Summary & High Accuracy Investment Signals - mfd.ru
Organigram launches 10 SKUs in Australian medical cannabis market - StratCann
Organigram (OGI) launches Edison and BOXHOT medical vapes, pastilles in Australia - Stock Titan
Organigram Expands Global Footprint With New Medical Cannabis Products in Australia - TipRanks
Organigram (OGI) Expands Product Line in Australia with New Laun - GuruFocus
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia - marketscreener.com
Organigram Launches New Products In Australia (NASDAQ:OGI) - Seeking Alpha
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia – Company AnnouncementFT.com - Financial Times
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Organigram Global Moves to Acquire Stake in Germany’s Sanity Group, Expanding European Cannabis Reach - TipRanks
Organigram to buy Berlin-based Sanity Group in €113.4M upfront deal, expanding cannabis supply network - MSN
Analysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and Spyre Therapeutics (SYRE) - The Globe and Mail
Organigram Global Inc Stock (OGI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):